SAKAR HEALTHCARE LIMITED (SAKAR) financials

SAKAR HEALTHCARE LIMITED (SAKAR) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products[1]

Market Cap: ₹2,140Cr.
Current Price: ₹962
Stock P/E: 59.3
ROE: 9.99%
ROCE: 12.4%
Book Value: ₹146
Dividend Yield: 0.00%
52W High / Low: ₹1,230/350

In Jun 2026, SAKAR HEALTHCARE LIMITED (SAKAR) reported sales ₹73 Cr and net profit ₹10 Cr.

Annual TTM: sales ₹272 Cr, net profit ₹36 Cr.

Shareholding: Promoters 51.70% (Sep 2026), FIIs 12.34% (Sep 2026), DIIs 11.92% (Sep 2026), Public 24.04% (Sep 2026), No. of Shareholders 19,539% (Sep 2026).

SAKAR quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	43	43	50	53	58	70	71	73
Expenses	31	32	35	40	46	52	45	52
Operating Profit	12	12	16	13	11	19	26	21
OPM %	27%	27%	31%	24%	20%	26%	37%	29%
Other Income	0	0	0	0	1	1	0	2
Interest	2	1	4	2	2	2	2	2
Depreciation	5	5	5	6	6	6	6	7
Profit before tax	5	5	6	5	5	11	18	15
Tax %	6%	17%	8%	13%	15%	6%	39%	29%
Net Profit	5	5	6	5	5	10	11	10
EPS in Rs	2.21	2.06	2.62	2.10	2.04	4.61	4.95	4.62
Raw PDF	—	—	—	—	—	—	—	—

SAKAR profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	83	95	128	133	153	178	251	272
Expenses	63	72	99	100	115	128	182	195
Operating Profit	20	23	29	33	38	50	69	77
OPM %	24%	24%	23%	25%	25%	28%	27%	28%
Other Income	2	1	2	5	3	1	2	3
Interest	2	2	3	6	8	9	8	7
Depreciation	7	8	10	15	18	21	24	25
Profit before tax	12	13	19	17	16	22	40	49
Tax %	21%	19%	20%	24%	27%	19%	23%	—
Net Profit	10	11	15	13	12	18	30	36
EPS in Rs	6.43	6.84	8.90	6.70	5.37	7.97	13.70	16.22
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	—

SAKAR balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	15	15	16	17	19	22	22	22
Reserves	57	66	83	110	154	241	264	302
Borrowings	11	17	43	93	119	79	86	71
Other Liabilities	15	17	37	47	44	47	43	86
Total Liabilities	97	115	178	268	336	389	415	481
Fixed Assets	64	66	69	205	267	314	309	326
CWIP	9	13	49	1	6	0	17	4
Investments	-0	0	0	7	3	0	0	0
Other Assets	25	36	60	55	60	74	90	151
Total Assets	97	115	178	268	336	389	415	481

SAKAR cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	16	19	15	36	33	24	34	49
Cash from Investing Activity	-25	-22	-47	-90	-74	-52	-31	-28
Cash from Financing Activity	9	3	32	55	41	27	-3	-21
Net Cash Flow	-0	-0	-0	-0	0	0	-0	-0
Free Cash Flow	-9	-4	-32	-62	-49	-35	2	21
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	104%	110%	67%	121%	113%	72%	73%	77%

SAKAR shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	53.58%	53.58%	52.86%	52.86%	52.86%	52.86%	52.52%	51.70%
FIIs	13.58%	13.61%	13.41%	13.31%	13.05%	12.94%	12.13%	12.34%
DIIs	10.88%	10.97%	11.25%	11.43%	11.36%	11.32%	11.37%	11.92%
Public	21.96%	21.85%	22.48%	22.41%	22.73%	22.87%	23.98%	24.04%
No. of Shareholders	8,598	8,608	8,115	7,565	7,069	9,580	14,734	19,539

SAKAR key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	51	36	48	40	60	50	63	73
Inventory Days	70	92	112	69	76	121	193	207
Days Payable	41	46	141	149	129	120	93	153
Cash Conversion Cycle	80	83	19	-39	7	51	163	127
Working Capital Days	31	31	2	-11	-6	29	52	45
ROCE %	16%	16%	13%	12%	9%	7%	9%	12%

SAKARUpdated 18 Oct 2026, 0:49

Sakar Healthcare Limited

SAKARUpdated 18 Oct 2026, 0:49

Market Cap

₹2,140Cr.

Current Price

₹962

High / Low

₹1,230/350

Stock P/E

59.3

ROE9.99%

ROCE12.4%

Book Value₹146

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	39	2	30	2	5	4	28	3	1.49
Sep 2023	34	2	25	1	4	4	13	4	1.7
Dec 2023	37	2	28	0	4	3	31	2	0.95
Mar 2024	43	2	32	1	5	5	35	3	1.43
Jun 2024	41	1	30	0	5	5	49	2	1.11
Sep 2024	43	2	31	0	5	5	6	5	2.21
Dec 2024	43	1	32	0	5	5	17	5	2.06
Mar 2025	50	4	35	0	5	6	8	6	2.62
Jun 2025	53	2	40	0	6	5	13	5	2.1
Sep 2025	58	2	46	1	6	5	15	5	2.04
Dec 2025	70	2	52	1	6	11	6	10	4.61
Mar 2026	71	2	45	0	6	18	39	11	4.95
Jun 2026	73	2	52	2	7	15	29	10	4.62

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	35	3	27	0	2	2	24	2	2.3
Mar 2016	41	3	33	0	3	3	22	2	2.78
Mar 2017	44	3	34	1	3	5	30	3	3.08
Mar 2018	53	3	40	0	4	6	38	4	3.12
Mar 2019	68	2	51	1	6	9	28	7	4.47
Mar 2020	83	2	63	2	7	12	21	10	6.43
Mar 2021	95	2	72	1	8	13	19	11	6.84
Mar 2022	128	3	99	2	10	19	20	15	8.9
Mar 2023	133	6	100	5	15	17	24	13	6.7
Mar 2024	153	8	115	3	18	16	27	12	5.37
Mar 2025	178	9	128	1	21	22	19	18	7.97
Mar 2026	251	8	182	2	24	40	23	30	13.7
TTM	272	7	195	3	25	49	—	36	16.22

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	51.7%
FIIs	12.34%
DIIs	11.92%
Public	24.04%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	53.15%	13.76%	10.62%	22.47%
Mar 2024	53.15%	13.52%	10.62%	22.71%
Jun 2024	53.15%	13.52%	10.62%	22.71%
Sep 2024	53.15%	13.42%	10.62%	22.8%
Dec 2024	53.58%	13.58%	10.88%	21.96%
Mar 2025	53.58%	13.61%	10.97%	21.85%
Jun 2025	52.86%	13.41%	11.25%	22.48%
Sep 2025	52.86%	13.31%	11.43%	22.41%
Dec 2025	52.86%	13.05%	11.36%	22.73%
Mar 2026	52.86%	12.94%	11.32%	22.87%
Jun 2026	52.52%	12.13%	11.37%	23.98%
Sep 2026	51.7%	12.34%	11.92%	24.04%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	8	7	25	11	50	36	0	0	14	50
Mar 2016	8	11	22	10	51	37	0	0	14	51
Mar 2017	11	25	24	11	71	49	0	0	22	71
Mar 2018	12	39	11	18	81	53	0	0	28	81
Mar 2019	15	57	11	15	97	64	9	0	25	97
Mar 2020	15	66	17	17	115	66	13	0	36	115
Mar 2021	16	83	43	37	178	69	49	0	60	178
Mar 2022	17	110	93	47	268	205	1	7	55	268
Mar 2023	19	154	119	44	336	267	6	3	60	336
Mar 2024	22	241	79	47	389	314	0	0	74	389
Mar 2025	22	264	86	43	415	309	17	0	90	415
Mar 2026	22	302	71	86	481	326	4	0	151	481

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	4	-1	-3	1
Mar 2016	9	-4	-6	-1
Mar 2017	2	-14	13	0
Mar 2018	5	-8	-13	-16
Mar 2019	16	-25	9	0
Mar 2020	19	-22	3	0
Mar 2021	15	-47	32	0
Mar 2022	36	-90	55	0
Mar 2023	33	-74	41	0
Mar 2024	24	-52	27	0
Mar 2025	34	-31	-3	0
Mar 2026	49	-28	-21	0

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	21	26	44	74	51	36	48	40	60	50	63	73
Inventory Days	142	107	114	51	70	92	112	69	76	121	193	207
Days Payable	20	66	51	57	41	46	141	149	129	120	93	153
Cash Conversion Cycle	143	67	107	68	80	83	19	-39	7	51	163	127
Working Capital Days	27	10	67	98	31	31	2	-11	-6	29	52	45
ROCE %	14%	14%	15%	14%	16%	16%	13%	12%	9%	7%	9%	12%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SAKAR HEALTHCARE LIMITED (SAKAR)?

The reported market capitalisation for SAKAR HEALTHCARE LIMITED (SAKAR) is ₹2,140Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SAKAR?

The current price shown for SAKAR HEALTHCARE LIMITED (SAKAR) on Fincrux is ₹962 with a 52-week high/low of ₹1,230/350.

What is the P/E ratio of SAKAR HEALTHCARE LIMITED (SAKAR)?

The stock P/E for SAKAR HEALTHCARE LIMITED (SAKAR) is 59.3 on Fincrux, with ROE at 9.99% and ROCE at 12.4%.

What were SAKAR latest quarterly results?

For Jun 2026, SAKAR HEALTHCARE LIMITED (SAKAR) reported sales ₹73 Cr and net profit ₹10 Cr (figures in ₹ crore unless noted).

What are SAKAR annual sales and net profit?

For TTM, SAKAR HEALTHCARE LIMITED (SAKAR) shows sales of ₹272 Cr and net profit of ₹36 Cr on the Fincrux profit & loss statement.

Who owns SAKAR HEALTHCARE LIMITED (SAKAR)?

Latest shareholding for SAKAR HEALTHCARE LIMITED (SAKAR) on Fincrux: Promoters 51.70% (Sep 2026), FIIs 12.34% (Sep 2026), DIIs 11.92% (Sep 2026), Public 24.04% (Sep 2026), No. of Shareholders 19,539% (Sep 2026).

Where can I find SAKAR HEALTHCARE LIMITED (SAKAR) financials?

SAKAR HEALTHCARE LIMITED (SAKAR) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SAKAR balance sheet and cash flow?

Yes. The SAKAR HEALTHCARE LIMITED (SAKAR) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 0:49